Heartflow (NASDAQ:HTFL) Price Target Raised to $45.00

Heartflow (NASDAQ:HTFL) had its price objective raised by investment analysts at Stifel Nicolaus from $40.00 to $45.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 45.11% from the company’s current price.

HTFL has been the subject of several other research reports. Robert W. Baird assumed coverage on shares of Heartflow in a report on Friday, July 31st. They set an “outperform” rating and a $34.00 price objective for the company. Piper Sandler restated an “overweight” rating on shares of Heartflow in a research report on Thursday, June 11th. Freedom Capital raised Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Finally, William Blair started coverage on Heartflow in a report on Monday, May 4th. They issued an “outperform” rating for the company. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Heartflow has an average rating of “Moderate Buy” and an average price target of $37.29.

Heartflow Stock Performance

HTFL opened at $31.01 on Friday. The firm has a market cap of $2.67 billion and a price-to-earnings ratio of -9.97. The firm’s 50-day simple moving average is $28.80 and its 200-day simple moving average is $27.70. Heartflow has a twelve month low of $20.13 and a twelve month high of $41.22.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. The firm’s quarterly revenue was up 47.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Heartflow will post -0.82 EPS for the current fiscal year.

Insider Buying and Selling at Heartflow

In related news, CEO John C.M. Farquhar sold 22,562 shares of Heartflow stock in a transaction on Monday, August 10th. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22. Following the completion of the sale, the chief executive officer directly owned 436,280 shares of the company’s stock, valued at $12,351,086.80. The trade was a 4.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $28.34, for a total value of $261,266.46. Following the sale, the insider directly owned 78,731 shares in the company, valued at $2,231,236.54. The trade was a 10.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 115,805 shares of company stock valued at $3,530,609 in the last quarter. Corporate insiders own 7.70% of the company’s stock.

Hedge Funds Weigh In On Heartflow

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HTFL. TrueMark Investments LLC increased its holdings in Heartflow by 1.4% during the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock worth $654,000 after purchasing an additional 379 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Heartflow in the fourth quarter valued at about $27,000. Strs Ohio boosted its position in shares of Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after buying an additional 1,200 shares during the period. Russell Investments Group Ltd. bought a new position in shares of Heartflow during the fourth quarter worth about $45,000. Finally, Legal & General Group Plc acquired a new stake in Heartflow in the 3rd quarter valued at approximately $59,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.